SONOS INC, 10-Q filed on 2/4/2026
Quarterly Report
v3.25.4
Cover - shares
 3 Months Ended
Dec. 27, 2025
Jan. 19, 2026
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Dec. 27, 2025  
Document Transition Report false  
Entity File Number 001-38603  
Entity Registrant Name SONOS, INC.  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 03-0479476  
Entity Address, Address Line One 301 Coromar Drive  
Entity Address, City or Town Santa Barbara  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 93117  
City Area Code 805  
Local Phone Number 965-3001  
Title of 12(b) Security Common Stock, $0.001 par value  
Trading Symbol SONO  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Small Reporting Company false  
Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   120,872,657
Entity Central Index Key 0001314727  
Document Fiscal Year Focus 2026  
Document Fiscal Period Focus Q1  
Amendment Flag false  
Current Fiscal Year End Date --10-03  
v3.25.4
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 27, 2025
Sep. 27, 2025
Current assets:    
Cash and cash equivalents $ 312,504 $ 174,668
Marketable securities 50,987 52,858
Accounts receivable, net 116,270 65,847
Inventories 125,332 171,020
Prepaids and other current assets 35,146 39,642
Total current assets 640,239 504,035
Property and equipment, net 65,547 72,277
Operating lease right-of-use assets 44,721 45,297
Goodwill 82,854 82,854
Intangible assets, net 70,932 75,356
Deferred tax assets 10,545 10,509
Other noncurrent assets 33,037 32,950
Total assets 947,875 823,278
Current liabilities:    
Accounts payable 203,812 184,109
Accrued expenses 87,688 79,094
Accrued compensation 21,711 21,331
Deferred revenue, current 22,283 21,771
Other current liabilities 52,675 46,107
Total current liabilities 388,169 352,412
Operating lease liabilities, noncurrent 52,101 53,288
Deferred revenue, noncurrent 61,256 59,453
Deferred tax liabilities 129 126
Other noncurrent liabilities 2,894 2,774
Total liabilities 504,549 468,053
Commitments and contingencies (Note 7)
Stockholders’ equity:    
Common stock, $0.001 par value 124 123
Treasury stock (47,782) (37,398)
Additional paid-in capital 505,709 502,775
Accumulated deficit (18,280) (112,078)
Accumulated other comprehensive income 3,555 1,803
Total stockholders’ equity 443,326 355,225
Total liabilities and stockholders’ equity $ 947,875 $ 823,278
v3.25.4
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares
Dec. 27, 2025
Sep. 27, 2025
Statement of Financial Position [Abstract]    
Common stock, par value (in USD per share) $ 0.001 $ 0.001
v3.25.4
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME - USD ($)
$ in Thousands
 3 Months Ended
Dec. 27, 2025
Dec. 28, 2024
Income Statement [Abstract]    
Revenue $ 545,662 $ 550,857
Cost of revenue 292,202 309,451
Gross profit 253,460 241,406
Operating expenses    
Research and development 59,762 80,838
Sales and marketing 65,273 86,644
General and administrative 28,009 25,831
Total operating expenses 153,044 193,313
Operating income 100,416 48,093
Other income (expense), net    
Interest income 1,348 1,861
Interest expense (116) (110)
Other income (expense), net 420 (6,029)
Total other income (expense), net 1,652 (4,278)
Income before provision for (benefit from) income taxes 102,068 43,815
Provision for (benefit from) income taxes 8,270 (6,422)
Net income $ 93,798 $ 50,237
Earnings per share:    
Basic (in USD per share) $ 0.78 $ 0.41
Diluted (in USD per share) $ 0.75 $ 0.40
Weighted-average shares used in computing earnings per share:    
Basic (in shares) 120,489,548 122,071,586
Diluted (in shares) 124,662,298 124,731,619
Total comprehensive income    
Net income $ 93,798 $ 50,237
Change in foreign currency translation adjustment 1,736 (1,116)
Net unrealized gain (loss) on marketable securities 16 (84)
Comprehensive income $ 95,550 $ 49,037
v3.25.4
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common stock
Additional paid-in capital
Treasury stock
Accumulated deficit
Accumulated other comprehensive income (loss)
Total stockholders' equity, beginning balances at Sep. 28, 2024 $ 428,620 $ 123 $ 498,245 $ (17,096) $ (50,934) $ (1,718)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock pursuant to equity incentive plans   2 2,409      
Retirement of treasury stock   0 4,867 4,867    
Stock-based compensation expense     25,334      
Repurchase of common stock, including excise tax and commission       (27,231)    
Repurchase of common stock related to shares withheld for tax in connection with vesting of stock awards       (9,044)    
Net income 50,237       50,237  
Change in foreign currency translation adjustment (1,116)         (1,116)
Unrealized gain (loss) on investments (84)         (84)
Total stockholders' equity, ending balances at Dec. 28, 2024 469,127 $ 125 521,121 $ (48,504) (697) (2,918)
Balances, beginning of period (in shares) at Sep. 28, 2024   123,046,510        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock pursuant to equity incentive plans (in shares)   2,103,983        
Retirement of treasury stock (in shares)   (421,210)        
Balances, ending of period (in shares) at Dec. 28, 2024   124,729,283        
Treasury stock, Beginning balances (in shares) at Sep. 28, 2024       (1,282,734)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Retirement of treasury stock (in shares)       421,210    
Repurchase of common stock (in shares)       (1,884,654)    
Repurchase of common stock related to shares withheld for tax in connection with vesting of stock awards (in shares)       (658,055)    
Treasury stock, ending balances (in shares) at Dec. 28, 2024       (3,404,233)    
Total stockholders' equity, beginning balances at Sep. 27, 2025 355,225 $ 123 502,775 $ (37,398) (112,078) 1,803
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock pursuant to equity incentive plans   3 13,229      
Retirement of treasury stock   2 25,486 25,489    
Stock-based compensation expense     15,191      
Repurchase of common stock, including excise tax and commission       (25,000)    
Repurchase of common stock related to shares withheld for tax in connection with vesting of stock awards       (10,873)    
Net income 93,798       93,798  
Change in foreign currency translation adjustment 1,736         1,736
Unrealized gain (loss) on investments 16         16
Total stockholders' equity, ending balances at Dec. 27, 2025 $ 443,326 $ 124 $ 505,709 $ (47,782) $ (18,280) $ 3,555
Balances, beginning of period (in shares) at Sep. 27, 2025   122,881,915        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock pursuant to equity incentive plans (in shares)   2,911,539        
Retirement of treasury stock (in shares)   (1,927,278)        
Balances, ending of period (in shares) at Dec. 27, 2025   123,866,176        
Treasury stock, Beginning balances (in shares) at Sep. 27, 2025       (2,788,802)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Retirement of treasury stock (in shares) 1,927,278     1,927,278    
Repurchase of common stock (in shares) (1,488,226)     (1,488,226)    
Repurchase of common stock related to shares withheld for tax in connection with vesting of stock awards (in shares)       (655,542)    
Treasury stock, ending balances (in shares) at Dec. 27, 2025       (3,005,292)    
v3.25.4
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 3 Months Ended
Dec. 27, 2025
Dec. 28, 2024
Cash flows from operating activities    
Net income $ 93,798 $ 50,237
Adjustments to reconcile net income to net cash provided by operating activities:    
Stock-based compensation expense 15,191 25,334
Depreciation and amortization 14,022 17,611
Provision for excess and obsolete inventory 153 1,305
Deferred income taxes 48 123
Other 2,025 841
Foreign currency transaction loss (gain) (1,625) 2,129
Changes in operating assets and liabilities:    
Accounts receivable (49,120) (41,374)
Inventories 45,534 89,308
Other assets 4,263 (6,437)
Accounts payable and accrued expenses 31,224 (5,940)
Accrued compensation 546 12,394
Deferred revenue 2,073 1,513
Other liabilities 5,175 9,129
Net cash provided by operating activities 163,307 156,173
Cash flows from investing activities    
Purchases of marketable securities (12,506) (10,128)
Purchases of property and equipment (5,958) (13,106)
Maturities of marketable securities 14,400 13,900
Net cash used in investing activities (4,064) (9,334)
Cash flows from financing activities    
Payments for repurchase of common stock (25,000) (27,165)
Payments for repurchase of common stock related to shares withheld for tax in connection with vesting of stock awards (10,873) (9,044)
Proceeds from exercise of stock options 13,232 2,411
Payments for debt issuance costs (780) 0
Net cash used in financing activities (23,421) (33,798)
Effect of exchange rate changes on cash and cash equivalents 2,014 (2,818)
Net increase in cash and cash equivalents 137,836 110,223
Cash and cash equivalents    
Beginning of period 174,668 169,732
End of period 312,504 279,955
Supplemental disclosure    
Cash paid for interest 67 63
Cash paid for taxes, net of refunds 1,469 658
Cash paid for amounts included in the measurement of lease liabilities, net of tenant improvement reimbursements received 1,899 (2,531)
Supplemental disclosure of non-cash investing and financing activities    
Purchases of property and equipment in accounts payable and accrued expenses 1,950 3,693
Right-of-use assets obtained in exchange for new operating lease liabilities 586 0
Excise tax on share repurchases, accrued but not paid $ 281 $ 668
v3.25.4
Business Overview and Basis of Presentation
 3 Months Ended
Dec. 27, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Business Overview and Basis of Presentation
1. Business Overview and Basis of Presentation
Description of business
Sonos, Inc. and its wholly owned subsidiaries (collectively, "Sonos," the "Company," "we," "us" or "our") designs, develops, manufactures, and sells audio products and services. The Sonos sound system provides customers with an immersive listening experience created by the design of its speakers, headphones and components, a proprietary software platform, and the ability to stream content from a variety of sources over the customer’s wireless network or over Bluetooth.
The Company’s products are sold through third-party physical retailers, including custom installers of home audio systems, select e-commerce retailers, and its website, sonos.com. The Company’s products are distributed in over 60 countries through its wholly owned subsidiaries: Sonos Europe B.V. in the Netherlands, Beijing Sonos Technology Co. Ltd. in China, Sonos Japan GK in Japan, and Sonos Australia Pty Ltd. in Australia.
Basis of presentation and preparation
The accompanying condensed consolidated financial statements are unaudited. The condensed consolidated balance sheet as of September 27, 2025, has been derived from the audited consolidated financial statements of the Company.
The accompanying condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America ("U.S. GAAP") for interim financial information and the applicable rules and regulations of the Securities and Exchange Commission ("SEC"). Accordingly, they do not include all the information and footnotes required by U.S. GAAP for annual financial statements. They should be read in conjunction with the consolidated financial statements and notes thereto contained in the Company’s Annual Report on Form 10-K for the fiscal year ended September 27, 2025, (the "Annual Report"), filed with the SEC on November 14, 2025.
In management’s opinion, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of only normal recurring adjustments, necessary for the fair statement of the Company’s financial position, its results of operations, and its cash flows for the interim periods presented. The results of operations for the three months ended December 27, 2025, are not necessarily indicative of the results to be expected for the full fiscal year or any other period.
The Company operates on a 52- week or 53- week fiscal year ending on the Saturday nearest September 30 each year. The Company’s fiscal year is divided into four quarters of 13 weeks, each beginning on a Sunday and containing two 4-week periods followed by a 5-week period. An additional week is included in the fourth fiscal quarter approximately every five years to realign fiscal quarters with calendar quarters. This last occurred in the fourth quarter of the Company’s fiscal year ended October 3, 2020, and will reoccur in the fiscal year ending October 3, 2026. The three months ended December 27, 2025 and December 28, 2024, spanned 13 weeks each. As used in this Quarterly Report on Form 10-Q, "fiscal 2026" refers to the fiscal year ending October 3, 2026, "fiscal 2025" refers to the fiscal year ended September 27, 2025, and "fiscal 2024" refers to the fiscal year ending September 28, 2024..
Use of estimates and judgments
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and judgments that affect the amounts reported and disclosed in the condensed consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates. On an ongoing basis, the Company evaluates its estimates and judgments compared to historical experience and expected trends.
Segment Information
The Company operates as one operating segment as it only reports aggregate financial information on a consolidated basis, accompanied by disaggregated information about revenue by geographic region and product category, to its Chief Executive Officer, who is the Company’s Chief Operating Decision Maker ("CODM"). The CODM reviews financial information on a consolidated basis for purposes of making operating decisions, allocating resources, and evaluating financial performance. The CODM uses consolidated net income (loss) to measure segment profit or loss and make key operating decisions, such as allocation of the budget and monitoring budget versus actual results.
Significant expenses within net income (loss) include cost of revenue, research and development, sales and marketing, and general and administrative, which are each separately presented on the Company’s condensed consolidated statements of operations and comprehensive income. Other segment items include interest income, interest expense, other income (expense), and provision for (benefit
from) income taxes, which are also each separately presented on the Company’s condensed consolidated statements of operations and comprehensive income. The CODM does not evaluate segment performance or allocate resources using asset information.
v3.25.4
Summary of Significant Accounting Policies
 3 Months Ended
Dec. 27, 2025
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies
2. Summary of Significant Accounting Policies
There have been no changes in the Company’s significant accounting policies, recently adopted accounting pronouncements, or recent accounting pronouncements pending adoption from those disclosed in the Annual Report, except as noted below.
Recent accounting pronouncements pending adoption
In December 2025, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update (“ASU”) No. 2025-11, Interim Reporting (Topic 270): Narrow-Scope Improvements. This update provides clarifications intended to improve the consistency and usability of interim disclosure requirements, including a comprehensive listing of required interim disclosures and a new disclosure principle for reporting material events occurring after the most recent annual reporting period. The amendments do not change the underlying objectives of interim reporting but are designed to enhance clarity in application. The amendments are effective for interim reporting periods within annual reporting periods beginning after December 15, 2027. The amendments may be applied retrospectively or prospectively, with early adoption permitted. The Company is currently evaluating the pronouncement to determine the impact it may have on the Company's consolidated financial statements and related disclosures.
In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures ("ASU 2023-09"). This update includes amendments that further enhance income tax disclosures, primarily through standardization and disaggregation of rate reconciliation categories and income taxes paid by jurisdiction. The amendments will be effective for our fiscal year ending October 3, 2026. The Company expects adoption of ASU 2023-09 to result in expanded income tax disclosures with no material impact on the Company's consolidated financial statements.
v3.25.4
Financial Instruments
 3 Months Ended
Dec. 27, 2025
Fair Value Disclosures [Abstract]  
Financial Instruments
3. Financial Instruments
The carrying values of the Company’s accounts receivable and accounts payable, approximate their fair values due to the short period of time to maturity or repayment. The Company utilizes the following fair value hierarchy to establish priorities of the inputs used to measure fair value:
•Level 1: Quoted prices in active markets for identical assets or liabilities.
•Level 2: Observable inputs other than quoted market prices included in Level 1, such as quoted prices for similar assets or liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.
The following table summarizes cash, cash equivalents and marketable securities by investment category as of December 27, 2025 and September 27, 2025:
December 27, 2025
Amortized CostUnrealized GainUnrealized LossEstimated Fair ValueCash and Cash EquivalentsMarketable Securities
Cash$109,219 $— $— $109,219 $109,219 $— 
Level 1:
Money market funds200,296 — — 200,296 200,296 — 
Subtotal200,296 — — 200,296 200,296 — 
Level 2:
U.S. Treasury securities53,935 44 (3)53,976 2,989 50,987 
Subtotal53,935 44 (3)53,976 2,989 50,987 
Total$363,450 $44 $(3)$363,491 $312,504 $50,987 
September 27, 2025
Amortized CostUnrealized GainUnrealized LossEstimated Fair ValueCash and Cash EquivalentsMarketable Securities
Cash$158,556 $— $— $158,556 $158,556 $— 
Level 1:
Money market funds16,112 — — 16,112 16,112 — 
Subtotal16,112 — — 16,112 16,112 — 
Level 2:
U.S. Treasury securities52,834 32 (8)52,858 — 52,858 
Subtotal52,834 32 (8)52,858 — 52,858 
Total$227,502 $32 $(8)$227,526 $174,668 $52,858 
Marketable securities
As of December 27, 2025, the Company held no securities with original maturities exceeding one year. There were no realized gains or losses on sales of marketable securities during the three months ended December 27, 2025.
For securities in an unrealized loss position, the Company does not intend to sell the securities, and it is more-likely-than-not that it will not be required to sell before recovery of their amortized cost basis. The Company evaluated whether the decline in fair value resulted from credit losses or other factors and concluded these amounts were related to temporary fluctuations in value of the securities and were due primarily to changes in interest rates and market conditions of the underlying securities. Accordingly, an allowance for credit losses was deemed unnecessary for these securities as of December 27, 2025.
Accrued interest receivable related to our marketable securities was nominal as of December 27, 2025. No accrued interest receivables were written off during the three months ended December 27, 2025.
v3.25.4
Revenue and Geographic Information
 3 Months Ended
Dec. 27, 2025
Revenue from Contract with Customer [Abstract]  
Revenue and Geographic Information
4. Revenue and Geographic Information
Disaggregation of revenue
Revenue includes the applicable service revenue for software upgrades and cloud-based services attributable to each region and is as follows:
Three Months Ended
December 27,
2025		December 28,
2024
(In thousands)
Americas$328,877 $324,583 
Europe, Middle East and Africa ("EMEA")189,441 197,612 
Asia Pacific ("APAC")27,344 28,662 
Total revenue$545,662 $550,857 
Revenue includes the applicable service revenue for software upgrades and cloud-based services attributable to each country and is as follows:
Three Months Ended
December 27,
2025		December 28,
2024
(In thousands)
United States$305,023 $294,629 
Other countries240,639 256,228 
Total revenue$545,662 $550,857 
Revenue by product category also includes the applicable service revenue for software upgrades and cloud-based services attributable to each product category and is as follows:
Three Months Ended
December 27,
2025		December 28,
2024
(In thousands)
Sonos speakers$459,240 $467,142 
Sonos system products65,058 60,274 
Partner products and other revenue21,364 23,441 
Total revenue$545,662 $550,857 
v3.25.4
Balance Sheet Components
 3 Months Ended
Dec. 27, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Balance Sheet Components
5. Balance Sheet Components
Accounts receivable, net
Accounts receivable, net consist of the following:
December 27,
2025		September 27,
2025
(In thousands)
Accounts receivable$223,360 $131,945 
Allowance for credit losses(3,011)(2,900)
Allowance for sales incentives(104,079)(63,198)
Accounts receivable, net of allowances$116,270 $65,847 
Inventories
Inventories consist of the following:
December 27,
2025		September 27,
2025
(In thousands)  
Finished goods$110,721 $153,485 
Component parts14,611 17,535 
Inventories$125,332 $171,020 
As of December 27, 2025 and September 27, 2025, the Company's reserves for excess and obsolete inventory were $41.3 million and $41.2 million, respectively.
Property and equipment
Property and equipment net of accumulated depreciation were as follows:
December 27,
2025		September 27,
2025
(In thousands)
Property and equipment
$273,190 $269,938 
Less: accumulated depreciation
(207,643)(197,661)
Property and equipment, net$65,547 $72,277 
Intangible assets
The following table reflects the changes in the net carrying amount of the components of intangible assets associated with the Company's acquisition activity:
December 27, 2025
Gross Carrying AmountAccumulated Amortization Foreign Currency TranslationNet Carrying Value
Weighted-Average Remaining Life
(In years)
(In thousands, except weighted-average remaining life)
Trade name$451 $(284)$16 $183 2.25
Technology-based94,419 (23,670)- 70,749 5.49
Total intangible assets$94,870 $(23,954)$16 $70,932 5.48
September 27, 2025
Gross Carrying AmountAccumulated Amortization Foreign Currency Translation Net Carrying Value
Weighted-Average Remaining Life
(In years)
(In thousands, except weighted-average remaining life)
Trade name
$451 $(264)$16 $203 2.50
Technology-based94,419 (19,266)- 75,153 5.73
Total intangible assets$94,870 $(19,530)$16 $75,356 5.73
The following table summarizes the estimated future amortization expense of the Company's intangible assets as of December 27, 2025:
Fiscal years endingFuture Amortization Expense
(In thousands)
Remainder of fiscal 2026$9,160 
202713,570 
202813,451 
202912,453 
203010,539 
2031 and thereafter11,759 
Total future amortization expense$70,932 
Cloud computing arrangements
Capitalized costs to implement cloud computing arrangements net of accumulated amortization are reported as a component of other noncurrent assets on the Company's condensed consolidated balance sheets and were as follows:
December 27,
2025		September 27,
2025
(In thousands)
Cloud computing implementation costs$27,411 $27,411 
Less: accumulated amortization(14,384)(13,320)
Cloud computing implementation costs, net$13,027 $14,091 
Amortization expense for implementation costs for cloud-based computing arrangements for the three months ended December 27, 2025 and December 28, 2024, were $1.1 million and $0.9 million, respectively.
Accrued expenses
Accrued expenses included the following:
December 27,
2025		September 27,
2025
(In thousands)
Accrued inventory and supply chain costs$35,816 $37,780 
Accrued taxes22,387 10,133 
Accrued advertising and marketing11,623 12,429 
Accrued general and administrative expenses9,268 8,923 
Accrued product development4,377 5,912 
Other accrued payables4,217 3,917 
Total accrued expenses$87,688 $79,094 
Deferred revenue
Amounts invoiced in advance of revenue recognition are recorded as deferred revenue on the condensed consolidated balance sheets. For the three months ended December 27, 2025 and December 28, 2024, deferred revenue included revenue allocated to unspecified software upgrades and cloud-based services of $82.7 million and $81.6 million, respectively, as well as current deferred revenue related to newly launched products sold to resellers not recognized as revenue until the date of general availability was reached.
The following table presents the changes in the Company’s deferred revenue:
Three Months Ended
December 27,
2025		December 28,
2024
(In thousands)
Deferred revenue, beginning of period$81,224 $82,877 
Recognition of revenue included in beginning of period deferred revenue(5,451)(8,221)
Revenue deferred, net of revenue recognized on contracts in the respective period7,766 7,562 
Deferred revenue, end of period$83,539 $82,218 
The Company expects the following recognition of deferred revenue as of December 27, 2025:
 For the fiscal years ending
 Remainder of 20262027202820292030 and
Beyond		Total
(In thousands)
Deferred revenue expected to be recognized$17,112 $19,482 $16,351 $12,771 $17,823 $83,539 
Other current liabilities
Other current liabilities consist of the following:
December 27,
2025		September 27,
2025
(In thousands)
Reserve for returns$26,553 $20,383 
Warranty liability10,649 10,002 
Short-term operating lease liabilities7,118 6,335 
Other 8,355 9,387 
Total other current liabilities$52,675 $46,107 
The following table presents the changes in the Company’s warranty liability:
December 27,
2025		December 28,
2024
(In thousands)
Warranty liability, beginning of period$10,002 $10,565 
Provision for warranties issued during the period3,951 5,475 
Settlements of warranty claims during the period(3,304)(5,119)
Warranty liability, end of period$10,649 $10,921 
v3.25.4
Debt
 3 Months Ended
Dec. 27, 2025
Debt Disclosure [Abstract]  
Debt
6. Debt
On October 13, 2021, the Company entered into a Revolving Credit Agreement (the "Revolving Credit Agreement") which was amended in October 2025 (“Amendment No. 2") with JPMorgan Chase Bank, N.A., KeyBank National Association and Goldman Sachs Bank USA. Amendment No. 2 provides for (i) a five-year senior secured revolving credit facility in the amount of up to 80.0 million and (ii) an uncommitted incremental facility subject to certain conditions. Proceeds are to be used for working capital and general corporate purposes. The facility may be drawn as an Alternative Base Rate Loan (at 1.00% plus an applicable margin) or Term Benchmark Loan (SOFR plus an applicable margin). The Company must also pay (i) an unused commitment fee ranging from 0.200% to 0.275% per annum of the average daily unused portion of the aggregate revolving credit commitment under the agreement and (ii) a per annum fee equal to the applicable margin over SOFR multiplied by the aggregate face amount of outstanding letters of credit. As of December 27, 2025, the Company did not have any outstanding borrowings and had $2.4 million in undrawn letters of credit that reduce the availability under the Revolving Credit Agreement.
The Company's obligations under the Revolving Credit Agreement are secured by substantially all of its assets. The Revolving Credit Agreement contains customary representations and warranties, customary affirmative and negative covenants, a financial covenant that is tested quarterly and requires the Company to maintain a certain consolidated leverage ratio, and customary events of default. As of December 27, 2025, the Company was in compliance with all financial covenants under the Revolving Credit Agreement.
v3.25.4
Commitments and Contingencies
 3 Months Ended
Dec. 27, 2025
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies
7. Commitments and Contingencies
Legal proceedings
From time to time, the Company is involved in legal proceedings in the ordinary course of business, including claims relating to employee relations, business practices, and patent infringement. Litigation can be expensive and disruptive to normal business operations. Moreover, the results of complex legal proceedings are difficult to predict, and the Company’s view of these matters may change in the future as the litigation and events related thereto unfold. The Company expenses legal fees as incurred. The Company records a provision for contingent losses when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. An unfavorable outcome to any legal matter, if material, could have an adverse effect on the Company’s operations or its financial position, liquidity or results of operations.
The Company’s Lawsuits Against Google:
On January 7, 2020, the Company filed a complaint with the U.S. International Trade Commission ("ITC") against Alphabet Inc. ("Alphabet") and Google LLC ("Google") and a counterpart lawsuit in the U.S. District Court for the Central District of California against Google. The complaint and lawsuit each allege infringement by Alphabet and Google of certain Sonos patents related to its smart speakers and related technology. The counterpart lawsuit was stayed pending completion of the ITC investigation and appeal thereof. The ITC concluded its investigation in January 2022, finding all five of the Company’s asserted patents to be valid and infringed by Google, and further finding that one redesign per patent proposed by Google would avoid infringement. The ITC issued a limited exclusion order and a cease-and-desist order with respect to Google’s infringing products. The Company and Google each appealed the ITC’s determination, which was upheld in its entirety by the appeals court. The stay in the counterpart lawsuit has been lifted. Google moved to file counterclaims on two of its own patents related to device setup and the court has added those patents to the case. No trial date has been set.
On September 29, 2020, the Company filed another lawsuit against Google alleging infringement of additional Sonos patents and seeking monetary damages and other non-monetary relief. A jury trial was held in May 2023, which found one Sonos patent to be infringed and another Sonos patent not infringed, and returned an award of $32.5 million based on a royalty rate of $2.30 per infringing unit. After trial, the court held Sonos’ patents unenforceable under the doctrine of prosecution laches and invalid as a result of amendments made during prosecution. In September 2025, the Federal Circuit overturned the lower court decision that had invalidated the jury verdict against Google, and is now set to decide the post-trial motions, including the Company’s motion for injunctive relief and additional damages.
Google’s Lawsuits Against the Company:
On June 11, 2020, Google filed a lawsuit in the U.S. District Court for the Northern District of California against the Company alleging infringement by the Company of five Google patents and seeking monetary damages and other non-monetary relief. All five of these patents have since been found invalid or non-infringed by the Court or by the U.S. Patent and Trademark Office or have been withdrawn from the case by Google. The Court has now entered final judgment for Sonos and against Google. Google has appealed the non-infringement rulings.
On August 8, 2022, Google filed two complaints with the ITC against the Company and two counterpart lawsuits in the Northern District of California against the Company, collectively alleging infringement by the Company of seven Google patents generally related to wireless charging, device setup, and voice control, and seeking monetary damages and other non-monetary relief. The counterpart lawsuits are stayed pending completion of the ITC investigations. In the first ITC investigation, the ITC terminated the investigation as to one Google patent as a result of the expiration of that Google patent and determined the other two Google patents to be invalid as indefinite, thus concluding the first investigation. Google has appealed this first ITC determination. The second ITC investigation concluded in December 2023 with a final determination of no violation by the Company. Google did not appeal this determination.
Implicit
On March 10, 2017, Implicit, LLC (“Implicit”) filed a patent infringement action in the United States District Court, District of Delaware against the Company. Implicit is asserting that the Company has infringed on certain claims of two patents in this case. The Company denies the allegations. The claims at issue have been held unpatentable by the U.S. Patent and Trademark Office. Implicit has appealed this ruling, and an oral argument related to the appeal was held by the Federal Circuit in October 2025. A range of loss, if any, associated with this matter is not probable or reasonably estimable as of December 27, 2025.
The Company is involved in certain other litigation matters not listed above but does not consider these matters to be material either individually or in the aggregate at this time. The Company’s view of the matters not listed may change in the future as the litigation and events related thereto unfold.
v3.25.4
Stockholders' Equity
 3 Months Ended
Dec. 27, 2025
Equity [Abstract]  
Stockholders' Equity
8. Stockholders' Equity
On February 24, 2025, the Board of Directors (the "Board") authorized a common stock repurchase program of up to $150.0 million. During the three months ended December 27, 2025, the Company repurchased 1,488,226 shares for an aggregate purchase price of $25.0 million and at an average price of $16.79 per share under the repurchase program. Aggregate purchase price and average price per share exclude commission and excise tax. As of December 27, 2025, the Company had $104.6 million available for share repurchases under the share repurchase program. The Company's share repurchases in excess of issuances are subject to a 1% excise tax enacted by the Inflation Reduction Act. Any excise tax incurred is recognized as part of the cost basis of the shares acquired in the condensed consolidated statements of equity.
Treasury stock during the three months ended December 27, 2025, included 655,542 shares withheld to satisfy employees' tax withholding requirements in connection with vesting of stock awards. Additionally, during the three months ended December 27, 2025, the Company retired 1,927,278 shares of treasury stock.
v3.25.4
Stock-based Compensation
 3 Months Ended
Dec. 27, 2025
Share-Based Payment Arrangement [Abstract]  
Stock-based Compensation
9. Stock-based Compensation
2018 Equity Incentive Plan
In July 2018, the Board adopted the 2018 Equity Incentive Plan (the "2018 Plan").
Stock options
The summary of the Company’s stock option activity is as follows:
Number of Options Weighted-Average Exercise PriceWeighted-Average Remaining Contractual TermAggregate Intrinsic Value
(In years)(In thousands)
Outstanding at September 27, 20255,544,885$14.28 1.5$5,850 
Exercised(935,584)$14.15  
Forfeited / expired(19,024)$15.15  
Outstanding at December 27, 20254,590,277$14.30 1.4$17,353 
As of December 27, 2025 and September 27, 2025, all outstanding stock options have vested and the Company had no unrecognized stock-based compensation expense related to stock options.
Restricted stock units ("RSU")
Pursuant to the 2018 Plan, the Company issues RSUs to employees and directors. The summary of the Company’s RSU activity is as follows:
Number of Units
Weighted-Average Grant Date Fair
Value		Aggregate Intrinsic Value
(In thousands)
Outstanding at September 27, 20258,777,387$12.96 $134,294 
Granted1,842,987$16.56  
Released(1,952,179)$13.26  
Forfeited(213,681)$13.29  
Outstanding at December 27, 20258,454,514$13.67 $152,858 
As of December 27, 2025 and September 27, 2025, the Company had $85.4 million and $78.1 million of unrecognized stock-based compensation expense related to RSUs, which are expected to be recognized over weighted-average periods of 2.6 years and 2.3 years, respectively.
Performance stock units ("PSU")
Pursuant to the 2018 Plan, the Company has issued and may issue certain PSUs that vest on the satisfaction of service and performance conditions. The number of outstanding PSUs is based on the target number of share awards. The number of shares vested at the end of the performance period is based on achievement of performance conditions and includes a performance adjustment to reflect the extent to which the corresponding performance goals have been achieved. The summary of the Company’s PSU activity is as follows:
Number of Units
Weighted-Average Grant Date Fair
Value		Aggregate Intrinsic Value
(In thousands)
Outstanding at September 27, 2025480,538$14.11 $7,352 
Granted273,855$18.04 
Released(23,776)$12.23 
Performance adjustment
(24,518)$18.65 
Outstanding at December 27, 2025706,099$15.54 $12,766 
As of December 27, 2025 and September 27, 2025, the Company had $7.8 million and $3.3 million of unrecognized stock-based compensation expense related to PSUs, which are expected to be recognized over weighted-average periods of 1.2 years and 1.3 years, respectively.
Stock-based compensation
Total stock-based compensation expense by functional category was as follows:
Three Months Ended
December 27,
2025		December 28,
2024
(In thousands)
Cost of revenue$1,327 $1,349 
Research and development6,489 13,315 
Sales and marketing2,845 5,632 
General and administrative4,530 5,038 
Total stock-based compensation expense$15,191 $25,334 
v3.25.4
Income Taxes
 3 Months Ended
Dec. 27, 2025
Income Tax Disclosure [Abstract]  
Income Taxes
10. Income Taxes
The Company’s income tax provision and the resulting effective tax rate for interim periods is generally determined based upon its estimated annual effective tax rate ("AETR"), adjusted for the effect of discrete items arising in that quarter. The impact of such inclusions could result in a higher or lower effective tax rate during a quarter, based upon the mix and timing of actual earnings or losses versus annual projections. In each quarter, the Company updates its estimate of the AETR, and if the estimated AETR changes, a cumulative adjustment is made in that quarter.
The Company recorded an income tax provision of $8.3 million and an income tax benefit of $6.4 million for the three months ended December 27, 2025 and December 28, 2024, respectively, related to U.S. and non-U.S. income taxes. The effective tax rate for the three months ended December 27, 2025 was favorably impacted by provisions of the One Big Beautiful Bill Act ("OBBBA"), including the repeal of the requirement to capitalize and amortize specified domestic research and experimental expenditures under Section 174 of the U.S. Internal Revenue Code. This resulted in a reduction in the Company’s US current tax expense with no impact to deferred tax expense as a result of the full valuation allowance maintained against the Company’s net U.S. deferred tax assets. The tax benefit for the three months ended December 28, 2024 primarily resulted from the application of a negative annual effective tax rate to year-to-date U.S. pre-tax income for the quarter, which was driven in part by the capitalization of research and experimental expenditures under Section 174 and the valuation allowance maintained against U.S. deferred tax assets.
In 2021, the Organization for Economic Cooperation and Development (“OECD”) released model rules for a global minimum tax (“Pillar Two Rules”), intended to ensure that large multinational enterprises are subject to an effective minimum tax rate of 15% in each jurisdiction in which they operate. Certain jurisdictions in which the Company conducts business have enacted local legislation implementing Pillar Two or equivalent minimum tax rules that apply for fiscal years beginning on or after January 1, 2024. In January 2026, the OECD released administrative guidance describing a coordinated “side-by-side” package applicable to certain U.S.-parented multinational groups for fiscal years beginning on or after January 1, 2026. Based on currently enacted legislation and available guidance, the Company does not expect the Pillar Two Rules to have a material impact on its effective tax rate for fiscal year 2026. The Company continues to monitor developments in Pillar Two legislation and guidance and will assess the impact of any legislative changes to future periods.
For the three months ended December 27, 2025, the Company concluded that a full valuation allowance on its deferred tax assets in the U.S. continued to be appropriate considering cumulative pre-tax losses in recent years and uncertainty with respect to future taxable income. Release of the valuation allowance in the U.S. would result in a benefit to the income tax provision in the period the release is recorded, which could have a material impact on net earnings. The timing and amount of the potential valuation allowance release are subject to significant management judgment, as well as prospective earnings in the U.S.
v3.25.4
Earnings Per Share
 3 Months Ended
Dec. 27, 2025
Earnings Per Share [Abstract]  
Earnings Per Share
11. Earnings Per Share
Earnings per share is calculated by dividing net income by the weighted-average number of shares of common stock outstanding less shares subject to repurchase. Diluted earnings per share adjusts the basic earnings per share and the weighted-average number of shares of common stock outstanding for the potentially dilutive impact of stock awards, using the treasury stock method.
The following table sets forth the computation of the Company’s basic and diluted earnings per share:
Three Months Ended
December 27,
2025		December 28,
2024
(In thousands, except share and per share data)
Numerator:
Net income - basic and diluted
$93,798 $50,237 
Denominator:
Weighted-average shares of common stock—basic120,489,548122,071,586
Effect of potentially dilutive stock options904,054 34,490 
Effect of RSUs3,070,274 2,616,466 
Effect of PSUs198,422 9,077 
Weighted-average shares of common stock—diluted124,662,298124,731,619
Earnings per share:
Basic$0.78 $0.41 
Diluted$0.75 $0.40 
The following shares were excluded from the computation of diluted net income per share because their effect would have been antidilutive:
Three Months Ended
December 27,
2025		December 28,
2024
Stock options to purchase common stock4,239,1936,934,553
Restricted stock units5,516,35013,147,922
Performance stock units160,0547,510
Total9,915,59720,089,985
v3.25.4
Retirement Plans
 3 Months Ended
Dec. 27, 2025
Retirement Benefits [Abstract]  
Retirement Plans
12. Retirement Plans
The Company has a defined contribution 401(k) plan (the "401(k) Plan") for the Company’s U.S.-based employees, as well as various defined contribution plans for its international employees. Eligible U.S. employees may make tax-deferred contributions under the 401(k) plan but are limited to the maximum annual dollar amount allowable under the Internal Revenue Code of 1986, as amended. The Company matches contributions towards the 401(k) Plan and international defined contribution plans. The Company's matching contributions totaled $2.1 million and $2.3 million for the three months ended December 27, 2025 and December 28, 2024, respectively.
v3.25.4
Insider Trading Arrangements
 3 Months Ended
Dec. 27, 2025
shares
Trading Arrangements, by Individual  
Non-Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Terminated false
Julius Genachowski [Member]  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
On November 20, 2025, Julius Genachowski, Chairperson and a member of our Board, amended his trading plan intended to satisfy the requirements of Rule 10b5-1(c) previously adopted August 14, 2025. The amended plan provides that Mr. Genachowski may sell up to 47,652 shares of common stock underlying options granted under our equity incentive plan. The plan terminates on the earlier of the date all shares under the plan are sold or November 5, 2027.
Julius Genachowski November 2025 Plan [Member] | Julius Genachowski [Member]  
Trading Arrangements, by Individual  
Name Julius Genachowski
Title Chairperson and a member of our Board
Rule 10b5-1 Arrangement Adopted true
Adoption Date November 20, 2025
Expiration Date November 5, 2027
Arrangement Duration 715 days
Aggregate Available 47,652
Julius Genachowski August 2025 Plan [Member] | Julius Genachowski [Member]  
Trading Arrangements, by Individual  
Name Julius Genachowski
Title Chairperson and a member of our Board
Rule 10b5-1 Arrangement Terminated true
Termination Date November 20, 2025
v3.25.4
Business Overview and Basis of Presentation (Policies)
 3 Months Ended
Dec. 27, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis of presentation and preparation
The accompanying condensed consolidated financial statements are unaudited. The condensed consolidated balance sheet as of September 27, 2025, has been derived from the audited consolidated financial statements of the Company.
The accompanying condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America ("U.S. GAAP") for interim financial information and the applicable rules and regulations of the Securities and Exchange Commission ("SEC"). Accordingly, they do not include all the information and footnotes required by U.S. GAAP for annual financial statements. They should be read in conjunction with the consolidated financial statements and notes thereto contained in the Company’s Annual Report on Form 10-K for the fiscal year ended September 27, 2025, (the "Annual Report"), filed with the SEC on November 14, 2025.
In management’s opinion, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of only normal recurring adjustments, necessary for the fair statement of the Company’s financial position, its results of operations, and its cash flows for the interim periods presented. The results of operations for the three months ended December 27, 2025, are not necessarily indicative of the results to be expected for the full fiscal year or any other period.
Fiscal period
The Company operates on a 52- week or 53- week fiscal year ending on the Saturday nearest September 30 each year. The Company’s fiscal year is divided into four quarters of 13 weeks, each beginning on a Sunday and containing two 4-week periods followed by a 5-week period. An additional week is included in the fourth fiscal quarter approximately every five years to realign fiscal quarters with calendar quarters. This last occurred in the fourth quarter of the Company’s fiscal year ended October 3, 2020, and will reoccur in the fiscal year ending October 3, 2026. The three months ended December 27, 2025 and December 28, 2024, spanned 13 weeks each. As used in this Quarterly Report on Form 10-Q, "fiscal 2026" refers to the fiscal year ending October 3, 2026, "fiscal 2025" refers to the fiscal year ended September 27, 2025, and "fiscal 2024" refers to the fiscal year ending September 28, 2024..
Use of estimates and judgments
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and judgments that affect the amounts reported and disclosed in the condensed consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates. On an ongoing basis, the Company evaluates its estimates and judgments compared to historical experience and expected trends.
Segment Information
The Company operates as one operating segment as it only reports aggregate financial information on a consolidated basis, accompanied by disaggregated information about revenue by geographic region and product category, to its Chief Executive Officer, who is the Company’s Chief Operating Decision Maker ("CODM"). The CODM reviews financial information on a consolidated basis for purposes of making operating decisions, allocating resources, and evaluating financial performance. The CODM uses consolidated net income (loss) to measure segment profit or loss and make key operating decisions, such as allocation of the budget and monitoring budget versus actual results.
Significant expenses within net income (loss) include cost of revenue, research and development, sales and marketing, and general and administrative, which are each separately presented on the Company’s condensed consolidated statements of operations and comprehensive income. Other segment items include interest income, interest expense, other income (expense), and provision for (benefit
from) income taxes, which are also each separately presented on the Company’s condensed consolidated statements of operations and comprehensive income. The CODM does not evaluate segment performance or allocate resources using asset information.
Recent accounting pronouncements pending adoption
In December 2025, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update (“ASU”) No. 2025-11, Interim Reporting (Topic 270): Narrow-Scope Improvements. This update provides clarifications intended to improve the consistency and usability of interim disclosure requirements, including a comprehensive listing of required interim disclosures and a new disclosure principle for reporting material events occurring after the most recent annual reporting period. The amendments do not change the underlying objectives of interim reporting but are designed to enhance clarity in application. The amendments are effective for interim reporting periods within annual reporting periods beginning after December 15, 2027. The amendments may be applied retrospectively or prospectively, with early adoption permitted. The Company is currently evaluating the pronouncement to determine the impact it may have on the Company's consolidated financial statements and related disclosures.
In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures ("ASU 2023-09"). This update includes amendments that further enhance income tax disclosures, primarily through standardization and disaggregation of rate reconciliation categories and income taxes paid by jurisdiction. The amendments will be effective for our fiscal year ending October 3, 2026. The Company expects adoption of ASU 2023-09 to result in expanded income tax disclosures with no material impact on the Company's consolidated financial statements.
v3.25.4
Financial Instruments (Tables)
 3 Months Ended
Dec. 27, 2025
Fair Value Disclosures [Abstract]  
Schedule of Fair Value, Assets Measured on Recurring Basis
The following table summarizes cash, cash equivalents and marketable securities by investment category as of December 27, 2025 and September 27, 2025:
December 27, 2025
Amortized CostUnrealized GainUnrealized LossEstimated Fair ValueCash and Cash EquivalentsMarketable Securities
Cash$109,219 $— $— $109,219 $109,219 $— 
Level 1:
Money market funds200,296 — — 200,296 200,296 — 
Subtotal200,296 — — 200,296 200,296 — 
Level 2:
U.S. Treasury securities53,935 44 (3)53,976 2,989 50,987 
Subtotal53,935 44 (3)53,976 2,989 50,987 
Total$363,450 $44 $(3)$363,491 $312,504 $50,987 
September 27, 2025
Amortized CostUnrealized GainUnrealized LossEstimated Fair ValueCash and Cash EquivalentsMarketable Securities
Cash$158,556 $— $— $158,556 $158,556 $— 
Level 1:
Money market funds16,112 — — 16,112 16,112 — 
Subtotal16,112 — — 16,112 16,112 — 
Level 2:
U.S. Treasury securities52,834 32 (8)52,858 — 52,858 
Subtotal52,834 32 (8)52,858 — 52,858 
Total$227,502 $32 $(8)$227,526 $174,668 $52,858 
v3.25.4
Revenue and Geographic Information (Tables)
 3 Months Ended
Dec. 27, 2025
Revenue from Contract with Customer [Abstract]  
Schedule of Disaggregation of Revenue
Revenue includes the applicable service revenue for software upgrades and cloud-based services attributable to each region and is as follows:
Three Months Ended
December 27,
2025		December 28,
2024
(In thousands)
Americas$328,877 $324,583 
Europe, Middle East and Africa ("EMEA")189,441 197,612 
Asia Pacific ("APAC")27,344 28,662 
Total revenue$545,662 $550,857 
Revenue includes the applicable service revenue for software upgrades and cloud-based services attributable to each country and is as follows:
Three Months Ended
December 27,
2025		December 28,
2024
(In thousands)
United States$305,023 $294,629 
Other countries240,639 256,228 
Total revenue$545,662 $550,857 
Revenue by product category also includes the applicable service revenue for software upgrades and cloud-based services attributable to each product category and is as follows:
Three Months Ended
December 27,
2025		December 28,
2024
(In thousands)
Sonos speakers$459,240 $467,142 
Sonos system products65,058 60,274 
Partner products and other revenue21,364 23,441 
Total revenue$545,662 $550,857 
v3.25.4
Balance Sheet Components (Tables)
 3 Months Ended
Dec. 27, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Accounts Receivable, Net
Accounts receivable, net consist of the following:
December 27,
2025		September 27,
2025
(In thousands)
Accounts receivable$223,360 $131,945 
Allowance for credit losses(3,011)(2,900)
Allowance for sales incentives(104,079)(63,198)
Accounts receivable, net of allowances$116,270 $65,847 
Schedule of Inventories
Inventories consist of the following:
December 27,
2025		September 27,
2025
(In thousands)  
Finished goods$110,721 $153,485 
Component parts14,611 17,535 
Inventories$125,332 $171,020 
Schedule of Property and Equipment
Property and equipment net of accumulated depreciation were as follows:
December 27,
2025		September 27,
2025
(In thousands)
Property and equipment
$273,190 $269,938 
Less: accumulated depreciation
(207,643)(197,661)
Property and equipment, net$65,547 $72,277 
Schedule of Intangible Assets
The following table reflects the changes in the net carrying amount of the components of intangible assets associated with the Company's acquisition activity:
December 27, 2025
Gross Carrying AmountAccumulated Amortization Foreign Currency TranslationNet Carrying Value
Weighted-Average Remaining Life
(In years)
(In thousands, except weighted-average remaining life)
Trade name$451 $(284)$16 $183 2.25
Technology-based94,419 (23,670)- 70,749 5.49
Total intangible assets$94,870 $(23,954)$16 $70,932 5.48
September 27, 2025
Gross Carrying AmountAccumulated Amortization Foreign Currency Translation Net Carrying Value
Weighted-Average Remaining Life
(In years)
(In thousands, except weighted-average remaining life)
Trade name
$451 $(264)$16 $203 2.50
Technology-based94,419 (19,266)- 75,153 5.73
Total intangible assets$94,870 $(19,530)$16 $75,356 5.73
Schedule of Estimated Future Amortization Expense
The following table summarizes the estimated future amortization expense of the Company's intangible assets as of December 27, 2025:
Fiscal years endingFuture Amortization Expense
(In thousands)
Remainder of fiscal 2026$9,160 
202713,570 
202813,451 
202912,453 
203010,539 
2031 and thereafter11,759 
Total future amortization expense$70,932 
Schedule of Cloud Computing Arrangements
Capitalized costs to implement cloud computing arrangements net of accumulated amortization are reported as a component of other noncurrent assets on the Company's condensed consolidated balance sheets and were as follows:
December 27,
2025		September 27,
2025
(In thousands)
Cloud computing implementation costs$27,411 $27,411 
Less: accumulated amortization(14,384)(13,320)
Cloud computing implementation costs, net$13,027 $14,091 
Schedule of Accrued Expenses
Accrued expenses included the following:
December 27,
2025		September 27,
2025
(In thousands)
Accrued inventory and supply chain costs$35,816 $37,780 
Accrued taxes22,387 10,133 
Accrued advertising and marketing11,623 12,429 
Accrued general and administrative expenses9,268 8,923 
Accrued product development4,377 5,912 
Other accrued payables4,217 3,917 
Total accrued expenses$87,688 $79,094 
Schedule of Changes in Deferred Revenue
The following table presents the changes in the Company’s deferred revenue:
Three Months Ended
December 27,
2025		December 28,
2024
(In thousands)
Deferred revenue, beginning of period$81,224 $82,877 
Recognition of revenue included in beginning of period deferred revenue(5,451)(8,221)
Revenue deferred, net of revenue recognized on contracts in the respective period7,766 7,562 
Deferred revenue, end of period$83,539 $82,218 
Schedule of Remaining Performance Obligation
The Company expects the following recognition of deferred revenue as of December 27, 2025:
 For the fiscal years ending
 Remainder of 20262027202820292030 and
Beyond		Total
(In thousands)
Deferred revenue expected to be recognized$17,112 $19,482 $16,351 $12,771 $17,823 $83,539 
Schedule of Other Current Liabilities
Other current liabilities consist of the following:
December 27,
2025		September 27,
2025
(In thousands)
Reserve for returns$26,553 $20,383 
Warranty liability10,649 10,002 
Short-term operating lease liabilities7,118 6,335 
Other 8,355 9,387 
Total other current liabilities$52,675 $46,107 
Schedule of Warranty Liability
The following table presents the changes in the Company’s warranty liability:
December 27,
2025		December 28,
2024
(In thousands)
Warranty liability, beginning of period$10,002 $10,565 
Provision for warranties issued during the period3,951 5,475 
Settlements of warranty claims during the period(3,304)(5,119)
Warranty liability, end of period$10,649 $10,921 
v3.25.4
Stock-based Compensation (Tables)
 3 Months Ended
Dec. 27, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Options Activity
The summary of the Company’s stock option activity is as follows:
Number of Options Weighted-Average Exercise PriceWeighted-Average Remaining Contractual TermAggregate Intrinsic Value
(In years)(In thousands)
Outstanding at September 27, 20255,544,885$14.28 1.5$5,850 
Exercised(935,584)$14.15  
Forfeited / expired(19,024)$15.15  
Outstanding at December 27, 20254,590,277$14.30 1.4$17,353 
Schedule of Restricted Stock Units Activity The summary of the Company’s RSU activity is as follows:
Number of Units
Weighted-Average Grant Date Fair
Value		Aggregate Intrinsic Value
(In thousands)
Outstanding at September 27, 20258,777,387$12.96 $134,294 
Granted1,842,987$16.56  
Released(1,952,179)$13.26  
Forfeited(213,681)$13.29  
Outstanding at December 27, 20258,454,514$13.67 $152,858 
Schedule of Performance Stock Units Activity The summary of the Company’s PSU activity is as follows:
Number of Units
Weighted-Average Grant Date Fair
Value		Aggregate Intrinsic Value
(In thousands)
Outstanding at September 27, 2025480,538$14.11 $7,352 
Granted273,855$18.04 
Released(23,776)$12.23 
Performance adjustment
(24,518)$18.65 
Outstanding at December 27, 2025706,099$15.54 $12,766 
Schedule of Stock Based Compensation Expense
Total stock-based compensation expense by functional category was as follows:
Three Months Ended
December 27,
2025		December 28,
2024
(In thousands)
Cost of revenue$1,327 $1,349 
Research and development6,489 13,315 
Sales and marketing2,845 5,632 
General and administrative4,530 5,038 
Total stock-based compensation expense$15,191 $25,334 
v3.25.4
Earnings Per Share (Tables)
 3 Months Ended
Dec. 27, 2025
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted
The following table sets forth the computation of the Company’s basic and diluted earnings per share:
Three Months Ended
December 27,
2025		December 28,
2024
(In thousands, except share and per share data)
Numerator:
Net income - basic and diluted
$93,798 $50,237 
Denominator:
Weighted-average shares of common stock—basic120,489,548122,071,586
Effect of potentially dilutive stock options904,054 34,490 
Effect of RSUs3,070,274 2,616,466 
Effect of PSUs198,422 9,077 
Weighted-average shares of common stock—diluted124,662,298124,731,619
Earnings per share:
Basic$0.78 $0.41 
Diluted$0.75 $0.40 
Schedule of Antidilutive Securities
The following shares were excluded from the computation of diluted net income per share because their effect would have been antidilutive:
Three Months Ended
December 27,
2025		December 28,
2024
Stock options to purchase common stock4,239,1936,934,553
Restricted stock units5,516,35013,147,922
Performance stock units160,0547,510
Total9,915,59720,089,985
v3.25.4
Business Overview and Basis of Presentation (Details)
 3 Months Ended
Dec. 27, 2025
segment
country
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Number of countries where products distributed | country 60
Number of operating segments 1
Number of reportable segments 1
v3.25.4
Financial Instruments - Schedule of Fair Value, Assets Measured on Recurring Basis (Details) - USD ($)
$ in Thousands
Dec. 27, 2025
Sep. 27, 2025
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Cash $ 109,219 $ 158,556
Amortized Cost 363,450 227,502
Unrealized Gain 44 32
Unrealized Loss (3) (8)
Estimated Fair Value 363,491 227,526
Cash and Cash Equivalents 312,504 174,668
Marketable securities 50,987 52,858
Level 1:    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Amortized Cost 200,296 16,112
Estimated Fair Value 200,296 16,112
Cash and Cash Equivalents 200,296 16,112
Level 1: | Money market funds    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Amortized Cost 200,296 16,112
Estimated Fair Value 200,296 16,112
Cash and Cash Equivalents 200,296 16,112
Level 2:    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Amortized Cost 53,935 52,834
Estimated Fair Value 53,976 52,858
Cash and Cash Equivalents 2,989 0
Unrealized Gain 44 32
Unrealized Loss (3) (8)
Marketable securities 50,987 52,858
Level 2: | U.S. Treasury securities    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Amortized Cost 53,935 52,834
Estimated Fair Value 53,976 52,858
Cash and Cash Equivalents 2,989 0
Unrealized Gain 44 32
Unrealized Loss (3) (8)
Marketable securities $ 50,987 $ 52,858
v3.25.4
Financial Instruments - Narrative (Details)
 3 Months Ended
Dec. 27, 2025
USD ($)
Fair Value Disclosures [Abstract]  
Debt securities, available-for-sale, noncurrent $ 0
Realized gain (loss) 0
Accrued interest 0
Accrued interest writeoff $ 0
v3.25.4
Revenue and Geographic Information (Details) - USD ($)
$ in Thousands
 3 Months Ended
Dec. 27, 2025
Dec. 28, 2024
Disaggregation of Revenue [Line Items]    
Total revenue $ 545,662 $ 550,857
Sonos speakers    
Disaggregation of Revenue [Line Items]    
Total revenue 459,240 467,142
Sonos system products    
Disaggregation of Revenue [Line Items]    
Total revenue 65,058 60,274
Partner products and other revenue    
Disaggregation of Revenue [Line Items]    
Total revenue 21,364 23,441
Americas    
Disaggregation of Revenue [Line Items]    
Total revenue 328,877 324,583
Europe, Middle East and Africa ("EMEA")    
Disaggregation of Revenue [Line Items]    
Total revenue 189,441 197,612
Asia Pacific ("APAC")    
Disaggregation of Revenue [Line Items]    
Total revenue 27,344 28,662
United States    
Disaggregation of Revenue [Line Items]    
Total revenue 305,023 294,629
Other countries    
Disaggregation of Revenue [Line Items]    
Total revenue $ 240,639 $ 256,228
v3.25.4
Balance Sheet Components - Schedule of Accounts Receivable, Net (Details) - USD ($)
$ in Thousands
Dec. 27, 2025
Sep. 27, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Accounts receivable $ 223,360 $ 131,945
Allowance for credit losses (3,011) (2,900)
Allowance for sales incentives (104,079) (63,198)
Accounts receivable, net of allowances $ 116,270 $ 65,847
v3.25.4
Balance Sheet Components - Schedule of Inventories (Details) - USD ($)
$ in Thousands
Dec. 27, 2025
Sep. 27, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Finished goods $ 110,721 $ 153,485
Component parts 14,611 17,535
Inventories $ 125,332 $ 171,020
v3.25.4
Balance Sheet Components - Narrative (Details) - USD ($)
$ in Millions
 3 Months Ended
Dec. 27, 2025
Dec. 28, 2024
Sep. 27, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]      
Reserves for excess and obsolete inventory $ 41.3   $ 41.2
Amortization expenses 1.1 $ 0.9  
Revenue recognized from previous period $ 82.7 $ 81.6  
v3.25.4
Balance Sheet Components - Schedule of Property and Equipment (Details) - USD ($)
$ in Thousands
Dec. 27, 2025
Sep. 27, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Property and equipment $ 273,190 $ 269,938
Less: accumulated depreciation (207,643) (197,661)
Property and equipment, net $ 65,547 $ 72,277
v3.25.4
Balance Sheet Components - Schedule of Intangible Assets (Details) - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Dec. 27, 2025
Sep. 27, 2025
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount $ 94,870 $ 94,870
Accumulated Amortization (23,954) (19,530)
Foreign Currency Translation 16 16
Total future amortization expense $ 70,932 $ 75,356
Weighted-Average Remaining Life (In years) 5 years 5 months 23 days 5 years 8 months 23 days
Trade name    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount $ 451 $ 451
Accumulated Amortization (284) (264)
Foreign Currency Translation 16 16
Total future amortization expense $ 183 $ 203
Weighted-Average Remaining Life (In years) 2 years 3 months 2 years 6 months
Technology-based    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount $ 94,419 $ 94,419
Accumulated Amortization (23,670) (19,266)
Foreign Currency Translation 0 0
Total future amortization expense $ 70,749 $ 75,153
Weighted-Average Remaining Life (In years) 5 years 5 months 26 days 5 years 8 months 23 days
v3.25.4
Balance Sheet Components - Schedule of Estimated Future Amortization Expense (Details) - USD ($)
$ in Thousands
Dec. 27, 2025
Sep. 27, 2025
Future Amortization Expense    
Remainder of fiscal 2026 $ 9,160  
2027 13,570  
2028 13,451  
2029 12,453  
2030 10,539  
2031 and thereafter 11,759  
Total future amortization expense $ 70,932 $ 75,356
v3.25.4
Balance Sheet Components - Schedule of Cloud Computing Arrangements (Details) - USD ($)
$ in Thousands
Dec. 27, 2025
Sep. 27, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Cloud computing implementation costs $ 27,411 $ 27,411
Less: accumulated amortization (14,384) (13,320)
Cloud computing implementation costs, net $ 13,027 $ 14,091
v3.25.4
Balance Sheet Components - Schedule of Accrued Expenses (Details) - USD ($)
$ in Thousands
Dec. 27, 2025
Sep. 27, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Accrued inventory and supply chain costs $ 35,816 $ 37,780
Accrued taxes 22,387 10,133
Accrued advertising and marketing 11,623 12,429
Accrued general and administrative expenses 9,268 8,923
Accrued product development 4,377 5,912
Other accrued payables 4,217 3,917
Total accrued expenses $ 87,688 $ 79,094
v3.25.4
Balance Sheet Components -Schedule of Changes in Deferred Revenue (Details) - USD ($)
$ in Thousands
 3 Months Ended
Dec. 27, 2025
Dec. 28, 2024
Contract with Customer, Liability [Roll Forward]    
Deferred revenue, beginning of period $ 81,224 $ 82,877
Recognition of revenue included in beginning of period deferred revenue (5,451) (8,221)
Revenue deferred, net of revenue recognized on contracts in the respective period 7,766 7,562
Deferred revenue, end of period $ 83,539 $ 82,218
v3.25.4
Balance Sheet Components - Schedule of Expected Recognition of Deferred Revenue (Details)
$ in Thousands
Dec. 27, 2025
USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Deferred revenue expected to be recognized $ 83,539
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-12-28  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Deferred revenue expected to be recognized $ 17,112
Revenue, remaining performance obligation, period 9 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-10-04  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Deferred revenue expected to be recognized $ 19,482
Revenue, remaining performance obligation, period 1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2027-10-03  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Deferred revenue expected to be recognized $ 16,351
Revenue, remaining performance obligation, period 1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2028-10-01  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Deferred revenue expected to be recognized $ 12,771
Revenue, remaining performance obligation, period 1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2029-09-30  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Deferred revenue expected to be recognized $ 17,823
Revenue, remaining performance obligation, period
v3.25.4
Balance Sheet Components - Schedule of Other Current Liabilities (Details) - USD ($)
$ in Thousands
Dec. 27, 2025
Sep. 27, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Reserve for returns $ 26,553 $ 20,383
Warranty liability 10,649 10,002
Short-term operating lease liabilities $ 7,118 $ 6,335
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Total other current liabilities Total other current liabilities
Other $ 8,355 $ 9,387
Total other current liabilities $ 52,675 $ 46,107
v3.25.4
Balance Sheet Components - Schedule of Warranty Liability (Details) - USD ($)
$ in Thousands
 3 Months Ended
Dec. 27, 2025
Dec. 28, 2024
Movement in Standard Product Warranty Accrual [Roll Forward]    
Warranty liability, beginning of period $ 10,002 $ 10,565
Provision for warranties issued during the period 3,951 5,475
Settlements of warranty claims during the period (3,304) (5,119)
Warranty liability, end of period $ 10,649 $ 10,921
v3.25.4
Debt (Details) - Credit Facility - USD ($)
$ in Millions
 1 Months Ended
Oct. 31, 2025
Dec. 27, 2025
Oct. 13, 2021
Revolving Credit Facility      
Debt Instrument [Line Items]      
Term of debt 5 years    
Maximum borrowing capacity     $ 80.0
Interest rate, spread on variable rate 1.00%    
Revolving Credit Facility | Minimum      
Debt Instrument [Line Items]      
Commitment fee percentage 0.20%    
Revolving Credit Facility | Maximum      
Debt Instrument [Line Items]      
Commitment fee percentage 0.275%    
Letter of Credit      
Debt Instrument [Line Items]      
Long-term debt   $ 2.4  
v3.25.4
Commitments and Contingencies (Details)
 1 Months Ended
Aug. 08, 2022
complaint
patent
lawsuit
Jun. 11, 2020
patent
Mar. 10, 2017
patent
May 31, 2023
USD ($)
patent
Jan. 31, 2022
patent
Lawsuits Against Google          
Loss Contingencies [Line Items]          
Gain contingency, patents found infringed upon       1 5
Amount awarded to other party | $       $ 32,500,000  
Royalty rate per infringing unit (in USD per share) | $       $ 2.30  
Google Lawsuits Against Sonos          
Loss Contingencies [Line Items]          
Loss contingency, patents allegedly infringed upon, number 7 5     2
Loss contingency, pending claims, number | complaint 2        
Loss contingency, number of defendants | lawsuit 2        
Loss contingency, patents found not infringed upon, number 1        
Loss contingency, patents found not to be indefinite-lived, number 2        
Implicit Against Sonos          
Loss Contingencies [Line Items]          
Loss contingency, patents allegedly infringed upon, number     2    
v3.25.4
Stockholders' Equity (Details) - USD ($)
$ / shares in Units, $ in Millions
 3 Months Ended
Dec. 27, 2025
Feb. 24, 2025
Equity [Abstract]    
Stock repurchase program, authorized amount   $ 150.0
Repurchase of common stock (in shares) 1,488,226  
Purchase price of common stock $ 25.0  
Average price per share (in USD per share) $ 16.79  
Remaining authorized repurchase amount $ 104.6  
Treasury stock withheld for employees' tax withholding requirements (in shares) 655,542  
Retirement of treasury stock (in shares) 1,927,278  
v3.25.4
Stock-based Compensation - Schedule of Stock Options Activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 12 Months Ended
Dec. 27, 2025
Sep. 27, 2025
Number of Options    
Beginning balance (in shares) 5,544,885  
Exercised (in shares) (935,584)  
Forfeited / expired (in shares) (19,024)  
Ending balance (in shares) 4,590,277 5,544,885
Weighted-Average Exercise Price    
Beginning balance (in USD per share) $ 14.28  
Exercised (in USD per share) 14.15  
Forfeited / expired (in USD per share) 15.15  
Ending balance (in USD per share) $ 14.30 $ 14.28
Weighted-Average Remaining Contractual Term 1 year 4 months 24 days 1 year 6 months
Aggregate Intrinsic Value $ 17,353 $ 5,850
v3.25.4
Stock-based Compensation - Narrative (Details) - USD ($)
 3 Months Ended 12 Months Ended
Dec. 27, 2025
Sep. 27, 2025
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Options, unrecognized stock-based compensation expense $ 0 $ 0
Restricted stock units    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Unrecognized stock-based compensation expense $ 85,400,000 $ 78,100,000
Unrecognized stock-based compensation expense, period of recognition 2 years 7 months 6 days 2 years 3 months 18 days
Performance stock units    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Unrecognized stock-based compensation expense $ 7,800,000 $ 3,300,000
Unrecognized stock-based compensation expense, period of recognition 1 year 2 months 12 days 1 year 3 months 18 days
v3.25.4
Stock-based Compensation - Schedule of Restricted Stock Units Activity (Details) - Restricted stock units - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended
Dec. 27, 2025
Sep. 27, 2025
Number of Units    
Outstanding, beginning balance (in shares) 8,777,387  
Granted (in shares) 1,842,987  
Released (in shares) (1,952,179)  
Forfeited (in shares) (213,681)  
Outstanding, ending balance (in shares) 8,454,514  
Weighted-Average Grant Date Fair Value    
Outstanding, beginning balance (in USD per share) $ 12.96  
Granted (in USD per share) 16.56  
Released (in USD per share) 13.26  
Forfeited (in USD per share) 13.29  
Outstanding, ending balance (in USD per share) $ 13.67  
Aggregate Intrinsic Value $ 152,858 $ 134,294
v3.25.4
Stock-based Compensation - Schedule of Performance Stock Units Activity (Details) - Performance stock units - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended
Dec. 27, 2025
Sep. 27, 2025
Number of Units    
Outstanding, beginning balance (in shares) 480,538  
Granted (in shares) 273,855  
Released (in shares) (23,776)  
Performance adjustment (in shares) (24,518)  
Outstanding, ending balance (in shares) 706,099  
Weighted-Average Grant Date Fair Value    
Outstanding, beginning balance (in USD per share) $ 14.11  
Granted (in USD per share) 18.04  
Released (in USD per share) 12.23  
Performance adjustment (in USD per share) 18.65  
Outstanding, ending balance (in USD per share) $ 15.54  
Aggregate Intrinsic Value $ 12,766 $ 7,352
v3.25.4
Stock-based Compensation - Schedule of Stock-based Compensation Expense (Details) - USD ($)
$ in Thousands
 3 Months Ended
Dec. 27, 2025
Dec. 28, 2024
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Total stock-based compensation expense $ 15,191 $ 25,334
Cost of revenue    
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Total stock-based compensation expense 1,327 1,349
Research and development    
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Total stock-based compensation expense 6,489 13,315
Sales and marketing    
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Total stock-based compensation expense 2,845 5,632
General and administrative    
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Total stock-based compensation expense $ 4,530 $ 5,038
v3.25.4
Income Taxes (Details) - USD ($)
$ in Thousands
 3 Months Ended
Dec. 27, 2025
Dec. 28, 2024
Income Tax Disclosure [Abstract]    
Income tax provision (benefit) $ 8,270 $ (6,422)
v3.25.4
Earnings Per Share - Schedule of Earnings Per Share, Basic and Diluted (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended
Dec. 27, 2025
Dec. 28, 2024
Numerator:    
Net income - basic $ 93,798 $ 50,237
Net income - diluted $ 93,798 $ 50,237
Denominator:    
Weighted-average shares of common stock - basic (in shares) 120,489,548 122,071,586
Weighted-average shares of common stock - diluted (in shares) 124,662,298 124,731,619
Earnings per share:    
Basic (in USD per share) $ 0.78 $ 0.41
Diluted (in USD per share) $ 0.75 $ 0.40
Effect of potentially dilutive stock options    
Denominator:    
Effect of potentially dilutive stock options, RSUs, and PSUs (in shares) 904,054 34,490
Effect of RSUs    
Denominator:    
Effect of potentially dilutive stock options, RSUs, and PSUs (in shares) 3,070,274 2,616,466
Effect of PSUs    
Denominator:    
Effect of potentially dilutive stock options, RSUs, and PSUs (in shares) 198,422 9,077
v3.25.4
Earnings Per Share - Schedule of Antidilutive Securities (Details) - shares
 3 Months Ended
Dec. 27, 2025
Dec. 28, 2024
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potentially antidilutive securities (in shares) 9,915,597 20,089,985
Stock options to purchase common stock    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potentially antidilutive securities (in shares) 4,239,193 6,934,553
Restricted stock units    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potentially antidilutive securities (in shares) 5,516,350 13,147,922
Performance stock units    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potentially antidilutive securities (in shares) 160,054 7,510
v3.25.4
Retirement Plans (Details) - USD ($)
$ in Millions
 3 Months Ended
Dec. 27, 2025
Dec. 28, 2024
Retirement Benefits [Abstract]    
Employer contribution $ 2.1 $ 2.3